Group B meningococcal vaccine: Recommendations for UK use

Andrew J. Pollard, Andrew Riordan, Mary Ramsay

Research output: Contribution to journalComment/debate

23 Citations (Scopus)
Original languageEnglish
Pages (from-to)1103-1104
Number of pages2
JournalThe Lancet
Issue number9923
Publication statusPublished - 2014

Bibliographical note

Funding Information:
AJP is Chair of the Joint Committee on Vaccination and Immunisation (JCVI). AR is Chair of the Meningococcal Subcommittee of the JCVI and was Acting Chair (2013) of the JCVI. MR is Head of Public Health England's Immunisation, Hepatitis and Blood Safety Department. AJP has conducted clinical trials of capsular group B meningococcal vaccines on behalf of Oxford University funded by the Wellcome Trust, Novartis Vaccines, and Pfizer, but has no personal pecuniary or other interests with any vaccine manufacturer. AR was lead editor for a Royal College of Paediatrics and Child Health eLearning package which was sponsored by Novartis. MR declares that she has no competing interests.

Copyright 2021 Elsevier B.V., All rights reserved.

Cite this